[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1025444T3 - Bestemmelse af cellulær vækstanormalitet - Google Patents

Bestemmelse af cellulær vækstanormalitet

Info

Publication number
DK1025444T3
DK1025444T3 DK98949123T DK98949123T DK1025444T3 DK 1025444 T3 DK1025444 T3 DK 1025444T3 DK 98949123 T DK98949123 T DK 98949123T DK 98949123 T DK98949123 T DK 98949123T DK 1025444 T3 DK1025444 T3 DK 1025444T3
Authority
DK
Denmark
Prior art keywords
proteins
determination
growth abnormalities
cellular growth
cancerous
Prior art date
Application number
DK98949123T
Other languages
English (en)
Inventor
Ronald Alfred Laskey
Gareth Haydn Williams
Nicholas Coleman
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9722217.8A external-priority patent/GB9722217D0/en
Priority claimed from GBGB9724134.3A external-priority patent/GB9724134D0/en
Priority claimed from GBGB9804156.9A external-priority patent/GB9804156D0/en
Priority claimed from GBGB9810560.4A external-priority patent/GB9810560D0/en
Priority claimed from GBGB9817075.6A external-priority patent/GB9817075D0/en
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of DK1025444T3 publication Critical patent/DK1025444T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57411—Specifically defined cancers of cervix
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Electrotherapy Devices (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Eye Examination Apparatus (AREA)
  • Peptides Or Proteins (AREA)
  • Liquid Crystal Substances (AREA)
DK98949123T 1997-10-21 1998-10-21 Bestemmelse af cellulær vækstanormalitet DK1025444T3 (da)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9722217.8A GB9722217D0 (en) 1997-10-21 1997-10-21 Determination of cellular growth abnormality
GBGB9724134.3A GB9724134D0 (en) 1997-11-14 1997-11-14 Determination of cellular growth abnormality
GBGB9804156.9A GB9804156D0 (en) 1998-02-26 1998-02-26 Determination of cellular growth abnormality
GBGB9810560.4A GB9810560D0 (en) 1998-05-15 1998-05-15 Determination of cellular growth abnormality
GBGB9817075.6A GB9817075D0 (en) 1998-08-05 1998-08-05 Determination of cellular growth abnormality
PCT/GB1998/003153 WO1999021014A1 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality
EP98949123A EP1025444B1 (en) 1997-10-21 1998-10-21 Determination of cellular growth abnormality

Publications (1)

Publication Number Publication Date
DK1025444T3 true DK1025444T3 (da) 2005-06-27

Family

ID=27517431

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98949123T DK1025444T3 (da) 1997-10-21 1998-10-21 Bestemmelse af cellulær vækstanormalitet

Country Status (23)

Country Link
EP (1) EP1025444B1 (da)
JP (2) JP2000511291A (da)
CN (1) CN1282422A (da)
AT (1) ATE290213T1 (da)
AU (1) AU751754B2 (da)
BR (1) BR9813127A (da)
CA (1) CA2305872C (da)
CO (1) CO5080817A1 (da)
DE (1) DE69829198T2 (da)
DK (1) DK1025444T3 (da)
ES (1) ES2239407T3 (da)
GB (1) GB2332515B (da)
HU (1) HUP0004134A2 (da)
IL (1) IL135602A0 (da)
IS (1) IS5456A (da)
MA (1) MA26557A1 (da)
NO (1) NO20002044L (da)
NZ (1) NZ503996A (da)
PE (1) PE20000121A1 (da)
PL (1) PL340057A1 (da)
PT (1) PT1025444E (da)
SK (1) SK5592000A3 (da)
WO (1) WO1999021014A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6361954B1 (en) 1996-05-02 2002-03-26 Cold Spring Harbor Laboratory Methods of immunoassay for human CDC6
GB0018140D0 (en) * 2000-07-24 2000-09-13 Medical Res Council Screening for abnormalities
DE10063179A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Verfahren zur spezifischen Detektion von Tumorzellen und ihren Vorstufen in Gebärmutterhalsabstrichen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
DE10063112A1 (de) 2000-12-18 2002-06-20 Bayer Ag Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
KR20030094281A (ko) 2001-03-12 2003-12-11 모노젠, 인크. 세포에 기초한 질병상태의 검출 및 질병상태의 구별
EP1369694A1 (en) 2002-04-09 2003-12-10 MTM Laboratories AG Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
EP1565581B1 (en) * 2002-08-20 2011-08-10 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
EP1422526A1 (en) 2002-10-28 2004-05-26 MTM Laboratories AG Method for improved diagnosis of dysplasias
WO2004074301A2 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Differentially expressed nucleic acids that correlate with ksp expression
US7361460B2 (en) 2003-04-11 2008-04-22 Digene Corporation Approach to molecular diagnosis of human papillomavirus-related diseases
US20070122909A1 (en) * 2003-10-20 2007-05-31 Syssmex Corporation Method of treating cells
ES2381644T3 (es) 2004-03-24 2012-05-30 Tripath Imaging, Inc. Métodos y composiciones para la detección de enfermedades de cuello uterino
US7595380B2 (en) 2005-04-27 2009-09-29 Tripath Imaging, Inc. Monoclonal antibodies and methods for their use in the detection of cervical disease
GB0518877D0 (en) * 2005-09-15 2005-10-26 Medical Res Council Markers and methods
US7632498B2 (en) 2005-12-19 2009-12-15 Tripath Imaging, Inc. MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
EP2487253B1 (en) 2006-01-05 2015-06-24 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
US7985584B2 (en) 2006-03-20 2011-07-26 The Ohio State University Research Foundation MicroRNA fingerprints during human megakaryocytopoiesis
DE102006020852A1 (de) 2006-05-04 2007-11-15 Robert Bosch Gmbh Gasdruckbehälter für gasbetriebene Kraftfahrzeuge
ES2570359T3 (es) 2007-08-03 2016-05-18 Univ Ohio State Res Found Regiones ultraconservadas que codifican ARNnc
GB0811567D0 (en) * 2008-06-24 2008-07-30 Cytosystems Ltd Assay
WO2011063382A1 (en) 2009-11-23 2011-05-26 The Ohio State University Materials and methods useful for affecting tumor cell growth, migration and invasion
GB0921873D0 (en) * 2009-12-15 2010-01-27 Cytosystems Ltd Assay
ES2606146T3 (es) 2010-11-12 2017-03-22 The Ohio State University Research Foundation Métodos relacionados con microARN-21 y reparación de desapareamiento en cáncer colorrectal
AU2011329066B2 (en) 2010-11-15 2017-03-09 The Ohio State University Research Foundation Controlled release mucoadhesive systems
WO2012090479A1 (en) * 2010-12-28 2012-07-05 Oncotherapy Science, Inc. Mcm7 as a target gene for cancer therapy and diagnosis
CA2852066A1 (en) 2011-10-14 2013-04-18 The Ohio State University Methods and materials related to ovarian cancer
US9481885B2 (en) 2011-12-13 2016-11-01 Ohio State Innovation Foundation Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
US9790556B2 (en) * 2012-01-05 2017-10-17 Centre National De La Recherche Scientifique (Cnrs) Signature for the diagnosis of lung cancer aggressiveness and genetic instability
WO2013110053A1 (en) 2012-01-20 2013-07-25 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis
US11306364B2 (en) 2012-02-18 2022-04-19 Duke University TERT promoter mutations in gliomas and a subset of tumors
JP6574385B2 (ja) * 2013-02-18 2019-09-11 デューク ユニバーシティー 神経膠腫および腫瘍のサブセットにおけるｔｅｒｔプロモーター変異
GB201412731D0 (en) * 2014-07-17 2014-09-03 Immunocore Ltd & Adaptimmune Ltd Peptides
WO2016180747A1 (en) * 2015-05-10 2016-11-17 Ventana Medical Systems, Inc. Compositions and methods for simultaneous inactivation of alkaline phosphatase and peroxidase enzymes during automated multiplex tissue staining assays
US11519916B2 (en) 2015-06-08 2022-12-06 Arquer Diagnostics Limited Methods for analysing a urine sample
GB201509907D0 (en) * 2015-06-08 2015-07-22 Urosens Ltd Antibodies
US11391744B2 (en) 2015-06-08 2022-07-19 Arquer Diagnostic Limited Methods and kits
GB201511196D0 (en) 2015-06-25 2015-08-12 Cytosystems Ltd Monoclonal antibodies
JP6245299B2 (ja) * 2016-04-27 2017-12-13 バクスアルタ ゲーエムベーハー 組換え安定細胞クローン、その産生およびその使用
CN106636343B (zh) * 2016-11-04 2021-03-19 深圳大学 一种检测口腔癌的标志物及其试剂盒
GB201820867D0 (en) * 2018-12-20 2019-02-06 Arquer Diagnostics Ltd Detection method
CN115453108A (zh) * 2019-12-11 2022-12-09 广东菲鹏生物有限公司 用于免疫诊断试剂中固相载体的封闭阶段处理剂及应用和产品

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8802196A1 (es) * 1984-03-30 1988-04-16 Syntex Inc Metodo para determinar la presion de un estado maligno en tejidos.
US5851821A (en) * 1996-05-02 1998-12-22 Cold Spring Harbor Laboratory DNA Replication-regulating genes
EP0812594A1 (en) * 1996-06-13 1997-12-17 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Compounds that interfere with DNA replication in rapidly proliferating cells for use in cancer therapy and methods for screening for such compounds
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
HUP0004134A2 (en) 2001-03-28
PL340057A1 (en) 2001-01-15
BR9813127A (pt) 2000-08-15
NO20002044L (no) 2000-06-07
GB9823069D0 (en) 1998-12-16
ATE290213T1 (de) 2005-03-15
JP2000511291A (ja) 2000-08-29
WO1999021014A1 (en) 1999-04-29
CA2305872A1 (en) 1999-04-29
CA2305872C (en) 2008-02-19
EP1025444B1 (en) 2005-03-02
GB2332515B (en) 1999-12-15
MA26557A1 (fr) 2004-12-20
SK5592000A3 (en) 2000-10-09
DE69829198D1 (de) 2005-04-07
DE69829198T2 (de) 2006-01-12
NO20002044D0 (no) 2000-04-18
PT1025444E (pt) 2005-07-29
AU9550298A (en) 1999-05-10
JP3774196B2 (ja) 2006-05-10
NZ503996A (en) 2002-04-26
JP2003240786A (ja) 2003-08-27
CO5080817A1 (es) 2001-09-25
IS5456A (is) 2000-04-17
AU751754B2 (en) 2002-08-29
GB2332515A (en) 1999-06-23
CN1282422A (zh) 2001-01-31
ES2239407T3 (es) 2005-09-16
PE20000121A1 (es) 2000-02-17
IL135602A0 (en) 2001-05-20
EP1025444A1 (en) 2000-08-09

Similar Documents

Publication Publication Date Title
DK1025444T3 (da) Bestemmelse af cellulær vækstanormalitet
AU2006200645B2 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
Mhawech et al. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma
CA2487048A1 (en) Method for solution based diagnosis
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
AU2003214909A1 (en) Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
Testori et al. Primary melanoma: from history to actual debates
DK0566571T3 (da) Diagnose af metastatisk cancer ved hjælp af mts-1-genet
EA200000845A1 (ru) Ген, кодирующий новый маркер рака
Reis Filho et al. p63 expression in sarcomatoid/metaplastic carcinomas of the breast
BR0010479A (pt) Gene tipo prp
AR014382A1 (es) Determinacion de anormalidad en el crecimiento celular
Tateishi et al. DNA polymerase‐α as a putative early relapse marker in non‐small cell lung cancer. An immunohistochemical study
TH41035B (th) การกำหนดของความผิดปกติในการเจริญเติบโตของเซลล์
Gupta et al. Tissue isoantigens A, B, and H in carcinoma of the cervix uteri: their clinical significance
TH41035A (th) การกำหนดของความผิดปกติในการเจริญเติบโตของเซลล์
BR0012301A (pt) Inibidores de crescimento de células epiteliais
Moyano et al. Alveolar soft part sarcoma presenting with cutaneous metastases: report of a case with immunohistochemical and molecular characterization
Pujol et al. Long term survival after pulmonary resection for small cell carcinoma of the lung.
Szymczyk et al. Colorectal cancer-associated nuclear antigen
Passlick et al. Detection of disseminated tumor cells in bone marrow of patients with resectable non-small cell lung cancer (NSCLC)-Long term results after 5 years of follow-up
Freeman Potential clinical applications of antibodies against the minichromosome maintenance (MCM) proteins
Veale et al. Pulmonary haemorrhage in Henoch-Schonlein purpura.
Halila Ovarian cancer-associated tumor markers CA 125 and TATI.